Investigation the Effect of Preoperation Oral and Infusion Riched Carbohydrate Diet on Postoperative Nausea, Vomiting and Quality of Recovery in Laparoscopic Surgery of Gallbladder Removal

Investigation the Effect of preoperation oral and Infusion Riched Carbohydrate Diet on Postoperative Nausea, Vomiting and Quality of Recovery in Laparascopic Cholecystectomy Surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017090231324N3

Enrollment

Registered

2017-11-08

Start date

2018-01-21

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis.

Interventions

Intervention 1: group1: 250 ml dextrose 10% infusion 2 hours before surgery. Intervention 2: group2: 200 ml oral carbohydrate solusion (includes 25 gram of dextrose 10%), 2 horse before surgery. Inter

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Elective Laparascopic cholecystectomy for Cholelithiasis Informed consent of patient

Exclusion criteria

Exclusion criteria: Acute cholecystitis and Urgent surgery Patients with open cholecystectomy surgery Diabetes mellitus Hepatic and Renal failure Chronic inflammatory bowel disease Acute recent infectoion Patient under corticosteroid therapy or Anabolic and Catabolic drugs Stomach empeting disorders Gastroesophageal reflux disease

Design outcomes

Primary

Measure	Time frame
Nausea and vomiting score. Timepoint: 1, 6 and 24 houre after surgery. Method of measurement: Visual Analogue Scale.;Quality of recovery Score. Timepoint: 1, 6 and 24 houre after surgery. Method of measurement: Quality Of Recovery Questionnaire.	—

Secondary

Measure	Time frame
Duration of hospitalization. Timepoint: duration of hospitalization after surgery. Method of measurement: patient hospitalization file.;Blood sugar. Timepoint: 2 houre before surgery, immediately after surgery and first day after operation at 8:00. Method of measurement: laboratory kit.;Duration of recovery. Timepoint: duration of pateint recovery time. Method of measurement: interview and inspection.;Pain score after surgery. Timepoint: severity of pain at 1, 6 and 24 hour after surgery. Method of measurement: Visual Analogue Scale.;Strat of starving. Timepoint: the time of patient desire to eat. Method of measurement: interview.;Duration of anesthesia. Timepoint: duration of patient anesthesia after surgery. Method of measurement: nursery records and inspection.;Surgery Complications. Timepoint: Any complication after surgery such as: Bleeding, Ulcer infection, Ileus, Pnomonia . Method of measurement: Patient File.;The amount of analgesic drug administered. Timepoint: after surgery. Method of measurement: patient file.;The amount of anti nausea drug administered. Timepoint: after surgery. Method of measurement: patent file.;Past medical history(diseae history). Timepoint: any disease during surgery. Method of measurement: interview.	—

Measure

Time frame

Duration of hospitalization. Timepoint: duration of hospitalization after surgery. Method of measurement: patient hospitalization file.;Blood sugar. Timepoint: 2 houre before surgery, immediately after surgery and first day after operation at 8:00. Method of measurement: laboratory kit.;Duration of recovery. Timepoint: duration of pateint recovery time. Method of measurement: interview and inspection.;Pain score after surgery. Timepoint: severity of pain at 1, 6 and 24 hour after surgery. Method of measurement: Visual Analogue Scale.;Strat of starving. Timepoint: the time of patient desire to eat. Method of measurement: interview.;Duration of anesthesia. Timepoint: duration of patient anesthesia after surgery. Method of measurement: nursery records and inspection.;Surgery Complications. Timepoint: Any complication after surgery such as: Bleeding, Ulcer infection, Ileus, Pnomonia . Method of measurement: Patient File.;The amount of analgesic drug administered. Timepoint: after surgery. Method of measurement: patient file.;The amount of anti nausea drug administered. Timepoint: after surgery. Method of measurement: patent file.;Past medical history(diseae history). Timepoint: any disease during surgery. Method of measurement: interview.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Hosseinpour

Iran University of Medical Sciences

Dr.parisahosseinpor@gmail.com+98 21 8670 3359

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026